Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Aerie Pharmaceuticals (NQ: AERI )

16.81 USD +0.31 (+1.88%)
Official Closing Price Updated: 7:42 PM EST, Jan 22, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Aerie Pharmaceuticals

< Previous 1 2 3 4 5 6 7 8 9
...
29 30 Next >
Aerie Pharmaceuticals Receives European Commission Approval for Roclanda® (netarsudil and latanoprost ophthalmic solution) 0.02%/0.005%
Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients... 
From Business Wire News Releases
Analysts Predict 15% Upside For The Holdings of IHE
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Bullish Two Hundred Day Moving Average Cross - AERI
In trading on Tuesday, shares of Aerie Pharmaceuticals Inc (AERI) crossed above their 200 day moving average of $13.09, changing hands as high as $13.12 per share. Aerie Pharmaceuticals Inc shares are... 
Tags Stocks
From Market News Video
First Week of AERI January 2021 Options Trading
Investors in Aerie Pharmaceuticals Inc (AERI) saw new options begin trading this week, for the January 2021 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the AERI... 
Tags Stocks
From Market News Video
The Math Shows IHE Can Go To $210
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Aerie Pharmaceuticals Receives Positive CHMP Opinion for Roclanda® in the European Union
Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients... 
From Business Wire News Releases
Aerie Pharmaceuticals to Participate in the Stifel 2020 Virtual Healthcare Conference
Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients... 
From Business Wire News Releases
Aerie Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Business Update
Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients... 
From Business Wire News Releases
The Daily Biotech Pulse: Bluebird Bio Plunges On Regulatory Filing Delay, Synlogic Soars On Study Initiation, European Label Expansion For Vertex, Merck Goes Shopping
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags KOD ATRS SAGE
From Benzinga
The Week Ahead In Biotech (Nov. 1-7): Adcom Test For Biogen's Aducanumab, Alzheimer's Conference, SMID-cap Earnings
Biotech stocks continued to sway to the tunes of the broader market in the week ended Oct. 30, which succumbed to geopolitical and ... 
Tags ANIK HBIO AMPH
From Benzinga
Aerie Pharmaceuticals Initiates Phase 2b Clinical Trial of AR-15512 (TRPM8 Agonist) Ophthalmic Solution for the Treatment of Patients with Dry Eye Disease
Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients... 
From Business Wire News Releases
Santen and Aerie Conclude Exclusive License Agreement for Rhopressa® and Rocklatan® in Japan and Several Other Asian Countries
Santen Pharmaceutical Co., Ltd. (“Santen”) and Aerie Pharmaceuticals, Inc. (NASDAQ: AERI, “Aerie”) announced that Santen and Aerie have entered into an exclusive development and commercialization... 
From Business Wire News Releases
Aerie Pharmaceuticals to Announce Third Quarter 2020 Financial Results and Host Conference Call on Thursday, November 5, 2020
Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients... 
From Business Wire News Releases
The Daily Biotech Pulse: FDA Vaccine Committee Meeting, Roche In $350M Deal for COVID-19 Treatment, Edwards Lifesciences Reports Q3 Beat
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags RHHBY Benzinga News
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Before 10 a.m. ET on Wednesday, 21 companies set new 52-week lows. Noteables: Equity Commonwealth (NYSE: EQC) was the ... 
Tags Market News HPR DSSI
From Benzinga
The Daily Biotech Pulse: Prothena Progress In Parkinson's Disease Pipeline, Fast Track For Xeris, Biogen Earnings
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags XTLB LH INSM
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Before 10 a.m. ET Tuesday, 14 stocks made new 52-week lows. Significant Points: The company with the largest market ... 
Tags PRQR TTNP AERI
From Benzinga
The Daily Biotech Pulse: Aptinyx Jumps On Positive Readout, Cara Executes Korsuva Licensing Deal, Cleveland BioLabs Rallies On Reverse Merger
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags PACB GILD APTX
From Benzinga
58 Biggest Movers From Yesterday
Gainers Kaixin Auto Holdings (NASDAQ: KXIN) shares climbed 293.7% to close at $8.15 on Monday after climbing over 55% on Friday. ... 
Tags AERI SMMC RWLK
From Benzinga
Mid-Afternoon Market Update: Dow Falls 250 Points; BioSpecifics Technologies Shares Spike Higher
Toward the end of trading Monday, the Dow traded down 0.90% to 28348.53 while the NASDAQ fell 0.92% to 11564.13. The S&P also fell, ... 
Tags HAL LAC RESI
From Benzinga
10 Healthcare Stocks Moving In Monday's Intraday Session
Gainers BOQI International (NASDAQ:BIMI) stock increased by 60.05% to $3.1 during Monday's regular session. Trading volume for ... 
Tags CNTG PCSA Top Gainers
From Benzinga
Mid-Day Market Update: Front Yard Residential Surges Following Buyout Deal; American Equity Shares Plunge
Midway through trading Monday, the Dow traded down 0.22% to 28543.59 while the NASDAQ fell 0.08% to 11662.62. The S&P also fell, ... 
Tags Penny Stocks Commodities Eurozone
From Benzinga
41 Stocks Moving In Monday's Mid-Day Session
Gainers Kaixin Auto Holdings (NASDAQ: KXIN) shares jumped 200% to $6.21 after climbing over 55% on Friday. JP Morgan, last week, ... 
Tags Internet Software & Services NLS FLUX
From Benzinga
Why Aerie Pharmaceuticals Is Trading Lower Today
Aerie Pharmaceuticals (NASDAQ: AERI) shares are trading lower on Monday after Bank of America downgraded the stock from Neutral to ... 
Tags Downgrades Benzinga AERI
From Benzinga
Stocks That Hit 52-Week Lows On Monday
On Monday morning, 17 companies achieved new lows for the year. Significant Points: The company with the largest ... 
Tags Market News GILD CPIX
From Benzinga
Benzinga's Top Upgrades, Downgrades For October 19, 2020
Upgrades According to Guggenheim, the prior rating for Bristol-Myers Squibb Company (NYSE: BMY) was changed from Neutral to Buy. ... 
Tags PAG top upgrades Analyst Ratings
From Benzinga
Analysts Anticipate SMMV To Hit $33
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Aerie Pharmaceuticals Announces Acceptance of Its Investigational New Drug Application for AR-15512 (TRPM8 Agonist) Eye Drop for Dry Eye Disease
Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients... 
From Business Wire News Releases
The Week Ahead In Biotech: FDA Decisions For Mesoblast And Eton, Coronavirus Vaccine Updates
Biotech stock reversed course lastweek, dragged lower by the broader market weakness. The week's news flow was headlined by ... 
Tags FDA CAPR IPOs
From Benzinga
3 Top Mid-Cap Stocks to Buy Right Now
Investors would be wise to steer clear of the bigger, more mainstream names until the recent volatility has run its course 
Tags REGN RHHB/Y AERI
From Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
29 30 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.